3.6 Administration of medications
Marked discrepancies between national guidelines [1] and recorded
answers were reported. The most common treatment administered for
bronchiolitis was high flow oxygen therapy (81.66%) followed by oxygen
therapy with nasal cannula or face mask (68.05%), hypertonic solution
(49.70%), inhaled short-acting beta-agonists (SABA) (39.64%), inhaled
epinephrine (21.30%), an inhaled corticosteroid (ICS) (17.16%),
systemic CS (64.52%), respiratory physiotherapy (8.88%), antibiotics
(4.73%), intravenous SABA (0.59%). Among paediatricians using systemic
CS, betamethasone was the most common CS administered (64.52%),
followed by methylprednisone (16.66%), prednisolone (7.26%),
beclometasone dipropionate (4.7%), and dexamethasone (4.7%). In line
with national guidelines [1], only 16.66% of the participants did
not administer systemic CS.